Back to discover
Drug

Cystine

In clinical development
Emerging researchLate-stage development
Also known as Cistina, L-Cystine, L-Dicysteine, L-alpha-Diamino-beta-dithiolactic acid+2 more

Cistina, L-Cystine, L-Dicysteine, L-alpha-Diamino-beta-dithiolactic acid, cystine (L-cystine), (R,R)-3,3'-dithiobis(2-aminopropanoic acid).

2
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Cystine
Aliases & brands
CistinaL-CystineL-DicysteineL-alpha-Diamino-beta-dithiolactic acidcystine (L-cystine)(R,R)-3,3'-dithiobis(2-aminopropanoic acid)
RxNorm CUI
3036
ChEMBL ID
CHEMBL590540
UNII
48TCX9A1VT

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Active studies
1
Recruiting
1
Late-stage (III+)
PHASE DISTRIBUTIONn = 1
Phase 31

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes5
Neoplasms2Amino Acid Transport System y+1Breast Neoplasms1Cystine1Glutamic Acid1
Journals, researchers & institutions
Top journals
  • Journal of experimental & clinical cancer research : CR1
  • Nature communications1
Leading researchers
  • Bolli E1
  • Calautti E1
  • Cavallo F1
  • Conti L1
  • Cossu C1
  • Gan B1
  • Hang Q1
  • Horbath A1
Leading institutions
free-text, unnormalised
  • Biocon Bristol Myers Squibb R&D Center1
  • Candiolo Cancer Institute1
  • Laboratory of Epithelial Stem Cell Biology and Signaling1
  • Laboratory of Immunotherapy1
  • Laboratory of Oncoimmunology1
  • The Barer Institute1

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Cystine in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials